Brief: Aequus partners with Camargo to support US regulatory strategy for development programs
Oct 3 (Reuters) - Aequus Pharmaceuticals Inc
* Aequus partners with Camargo to support US regulatory
strategy for development programs
* Will issue 133,043 common shares of co to camargo in
connection with execution of agreement
* Under terms of agreement, Camargo will be compensated with
a split of cash and common shares of Co for services provided
* Camargo will be providing end-to-end regulatory consulting
services for Aequus' three development programs
Source text for Eikon: ID:nCCN9pwzKc
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange